Clinical Trials
32 trialsPhase II Clinical Study of LTC004 in Patients With Advanced Sarcoma
Letolab
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Tracon Pharmaceuticals Inc.
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Salarius Pharmaceuticals, LLC
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
SeliGIST
Grupo Espanol de Investigacion en Sarcomas
REGOMUNE
Institut Bergonié
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
ANNA-SARC
Maria Sklodowska-Curie National Research Institute of Oncology
METROmaJX
Institut Bergonié
A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
AlaMab Therapeutics (Shanghai) Inc.
TQBSP
Peking University People's Hospital
Combination Immunotherapy Targeting Sarcomas
Shenzhen Geno-Immune Medical Institute
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Shenzhen Geno-Immune Medical Institute
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
NanoCarrier Co., Ltd.
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Northwestern University
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
ADCVCTAST
N.N. Petrov National Medical Research Center of Oncology
NKEXPSARC
National University Hospital, Singapore
Anlotinib and Irinotecan for Ewing Sarcoma
Peking University People's Hospital
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma
Lee's Pharmaceutical Limited
PROPAN
Assistance Publique Hopitaux De Marseille
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Medical Research Council
GEIS-27
Broto, Javier MartÃn, M.D.
HYPROSAR
Kantonsspital Aarau
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
National Cancer Institute (NCI)
OSCAT
Tata Memorial Hospital
SUNXRT
Australasian Sarcoma Study Group
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
Grupo Espanol de Investigacion en Sarcomas